IL2 and systemic lupus erythematosus: Additionally, enhancing the function or expansion of regulatory T cells (Tregs), which are vital for maintaining immune tolerance, has been studied in conditions like systemic lupus erythematosus (SLE) and type 1 diabetes, with therapies such as low-dose IL-2 showing promise [37].